2005 Pilot study of radiation therapy 5-fluorouracil and leucovorin in extrapelvic gastrointestinal cancer
โ Scribed by R. Swaminathan; J.A. Martenson; P.A. Burch; R.G. Santala; G. Schroeder; H.C. Pitot; A.K. Hatfield; K. Wright; J.W. Kugler; P.L. Schaefer; G.R. Garton
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 117 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. The encouraging results seen in patients who received postoperative combined modality therapy in the adjuvant setting have prompted increased interest in preoperative combined modality therapy for patients with unresectable rectal cancer. The authors report the local control and survival
## BACKGROUND. This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin. ## METHODS. Pelvic radiation therapy consisted of 50.4 -54 gray (Gy) administered in 28 -30 fractions. Systemic treatment